Biotech

Latest Articles

Cassava spends $40M over apparently deceptive Alzheimer's update

.Cassava Sciences has actually accepted to pay $40 million to settle an inspection into insurance cl...

Merck bags alternatives on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has actually picked up choices on two Evaxion Biotech injection candidates, paying $...

Enanta's RSV antiviral crushes viral bunch in challenge study

.Enanta Pharmaceuticals has connected its own respiratory syncytial virus (RSV) antiviral to notable...

Biogen cans SAGE-324 cooperation after necessary trembling fall short

.Biogen has actually provided the final ceremonies to its own partnership with Sage Rehabs on SAGE-3...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion ratings

.On the exact same day that some Parkinson's disease medicines are actually being actually disputed,...

Arch finalizes $3B-plus fund to encourage biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Resources Life Sciences, Arc Venture Allies is a...

Orion to make use of Aitia's 'electronic doubles' to discover brand new cancer cells drugs

.Finnish biotech Orion has spied potential in Aitia's "digital double" technology to establish brand...

Windtree's surprise med brings up high blood pressure in latest phase 2 gain

.While Windtree Therapies has actually battled to increase the financial roots needed to have to end...

2 cancer biotechs merge, generating international footprint

.OncoC4 is actually taking AcroImmune-- and also its internal scientific manufacturing abilities-- u...

Amgen reports very first phase 3 win for $400M eczema drug

.Amgen has discussed (PDF) the 1st phase 3 records on its $400 thousand dermatitis medicine, connect...

Biogen, UCB document stage 3 lupus succeed after falling short earlier trial

.Biogen and UCB's bank on improving in to phase 3 astride an unsuccessful research study wants to ha...

Aptadir hopes new RNA preventions can easily reverse tricky cancers cells

.Italian biotech Aptadir Rehabs has actually released with the promise that its pipe of preclinical ...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has fulfilled its own objective in a Duchenne muscle dystrophy (DMD) resear...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...

Achilles drips cell therapy system, braces for unemployments after missing 'commercial viability' objectives

.Achilles Therapies has actually wrecked its own approach. The English biotech is stopping work on i...

Aligos trumpets period 2 MASH gain, lowering liver body fat around 46%

.Aligos Rehabs is heralding a midstage gain in metabolic-dysfunction associated steatohepatitis (MAS...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building brand-new antifungals has acquired a significant increase com...

Capricor markets Europe liberties to late-stage DMD therapy for $35M

.Having presently scooped up the USA legal rights to Capricor Therapies' late-stage Duchenne muscle ...

FDA junks adcomm for Applied's uncommon illness medicine

.After pushing back the selection meeting for Applied Rehabs' metabolic disorder drug govorestat, th...

Novo inks $600M NanoVation package to analyze genetic drugs ex-liver

.Novo Nordisk is continuing its press into genetic medicines, accepting compensate NanoVation Therap...